Is a complete TPEX/8432 research report available?

No complete published report is available for tpex/8432 (TPEX/8432) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/8432 stock profile: metrics, valuation and analysis

Market cap	1.9B
Revenue (ttm)	1.4B
Net income (ttm)	167.2M
EPS (ttm)	NT$4.35
Shares out	38.4M
P/E (trailing)	11.5x
Dividend	NT$2.61 (5.19%)
Volume	23,151
Beta	0.31

All TPEX/8432 indicators

Market & fundamental data

Available fields

250

Groups with data

Currency

TWD

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	76
Employees Change	-4%
Employees Change Percent	-5
Enterprise value	TWD 1.1B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	40.55
Isin	TW0008432006
Last refreshed	2026-09-12
Market cap	TWD 1.9B
Price	TWD 50
Price currency	TWD
Rev Per Employee	18,376,500x
Sector	Healthcare
Sector PE	88.31
Sector PE Fwd	27.72
Sic	2834
Symbol	tpex/8432
Website	https://www.tshbiopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.71%
EV Earnings	6.79x
EV/EBIT	4.49x
EV/EBITDA	4.07x
EV/FCF	4.08x
EV/Sales	0.81x
FCF yield	14.51%
P/B ratio	1.14x
P/E ratio	11.5x
P/S ratio	1.37x
PE Ratio10 Y	32.29x
PE Ratio3 Y	20.9x
PE Ratio5 Y	24.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.12%
EBITDA Margin	19.09%
FCF margin	19.94%
Gross margin	51.66%
Gross Profit	TWD 721.6M
Gross Profit Growth	13.97%
Gross Profit Growth Q	23.25%
Gross Profit Growth3 Y	19.34%
Gross Profit Growth5 Y	22.1%
Net Income	TWD 167.2M
Net Income Growth	45.7%
Net Income Growth Q	74.99%
Net Income Growth Qo Q	18.41%
Net Income Growth Quarters	5%
Net Income Growth Years	4%
Net Income Growth3 Y	44.74%
Net Income Growth5 Y	26.07%
Pretax Margin	19.36%
Profit Margin	11.97%
Profit Per Employee	TWD 2.2M
Profitable Quarters	TWD 15
Profitable Years	7
ROA	8.16
Roa5y	4.52
ROCE	15.04
ROE	13.44
Roe5y	7.16
ROIC	30.74
Roic5y	15.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.87%
Cagr15y	1.53%
Cagr1y	2.71%
Cagr3y	6.51%
Cagr5y	9.08%
Div CAGR10	2.2%
Div CAGR3	17.72%
Div CAGR5	7.71%
EPS Growth	45.96
EPS Growth Q	75
EPS Growth Qo Q	18.02
EPS Growth Quarters	5
EPS Growth Years	2
EPS Growth3 Y	44.89
EPS Growth5 Y	26.18
FCF Growth	56.52%
FCF Growth Q	5.38%
FCF Growth Qo Q	-74.4%
FCF Growth3 Y	127.01%
FCF Growth5 Y	35.53%
OCF Growth	53.08%
OCF Growth Q	1.12%
OCF Growth Qo Q	-74.22%
OCF Growth10 Y	15.28%
OCF Growth3 Y	116.43%
OCF Growth5 Y	34.85%
Revenue Growth	12.99x
Revenue Growth Q	22.8x
Revenue Growth Qo Q	15.7x
Revenue Growth Quarters	1x
Revenue Growth Years	4x
Revenue Growth3 Y	19.13x
Revenue Growth5 Y	26.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.72
Assets	TWD 2B
Cash	TWD 1.1B
Current Assets	TWD 1.5B
Current Liabilities	TWD 343.6M
Debt	TWD 15.1M
Debt EBITDA	TWD 0.05
Debt Equity	TWD 0.01
Debt FCF	TWD 0.05
Equity	TWD 1.7B
Interest Coverage	314
Liabilities	TWD 348.7M
Long Term Assets	TWD 537.5M
Long Term Liabilities	TWD 5M
Net Cash	TWD 1B
Net Cash By Market Cap	TWD 54.51
Net Cash Growth	16.78%
Net Debt EBITDA	TWD -3.93
Net Debt Equity	TWD -0.62
Net Debt FCF	TWD -3.76
Tangible Book Value	TWD 1.1B
Tangible Book Value Per Share	TWD 29.3
WACC	5.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.33
Inventory Turnover	4.33
Net Working Capital	TWD 93.4M
Quick ratio	3.67
Working Capital	TWD 1.1B
Working Capital Turnover	TWD 1.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%
Dividend Growth	23.11%
Dividend Growth Years	1%
Dividend per share	TWD 2.61
Dividend Years	16
Dividend Yield	5.19%
Ex Div Date	2026-06-12
Last Dividend	TWD 2.61
Payout Frequency	Annual
Payout Ratio	48.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-17.16%
1Y total return	2.7%
200-day SMA	52.56
3Y total return	20.84%
50-day SMA	50.39
50-day SMA vs 200-day SMA	50under200
5Y total return	54.39%
All Time High	116.1
All Time High Change	-56.94%
All Time High Date	2012-03-26
All Time Low	34.95
All Time Low Change	43.06%
All Time Low Date	2015-08-25
ATR	0.69
Beta	0.31
Beta1y	0.19
Beta2y	0.4
Ch YTD	-14.53
High	50.4
High52	59.3
High52 Date	2025-12-16
High52ch	-15.68%
Low	49.7
Low52	48.6
Low52 Date	2026-05-14
Low52ch	2.88%
Ma50ch	-0.77%
Price vs 200-day SMA	-4.87%
RSI	44.73
RSI Monthly	44.79
RSI Weekly	44
Sharpe ratio	0.29x
Sharpe Ratio3y	0.17x
Sharpe Ratio5y	0.26x
Sortino ratio	0.77
Sortino Ratio3y	0.47
Sortino Ratio5y	0.64
Total Return	5.14%
Tr YTD	-10.11
Tr15y	25.55%
Tr1m	-1.57%
Tr1w	-1.77%
Tr3m	-0.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,691,950%
Net Borrowing	-12,565,000
Shares Insiders	2.15%
Shares Institutions	0.72%
Shares Out	38,398,140
Shares Qo Q	-0.11%
Shares Yo Y	0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	36,983.2x
Bv Per Share	36.85
CAPEX	TWD -1.5M
Ch10y	-41.38
Ch15y	-24.38
Ch1m	-1.57
Ch1w	-1.77
Ch1y	-2.34
Ch3m	-5.66
Ch3y	7.88
Ch5y	28.37
Ch6m	-1.96
Change	0.3%
Change From Open	0.2
Close	49.85
Days Gap	0.1
Depreciation Amortization	13,490,000
Dollar Volume	1,157,550
Earnings Date	2026-09-14
EBIT	TWD 253.1M
EBITDA	TWD 266.6M
EPS	TWD 4.35
F Score	6
FCF	TWD 278.5M
FCF EV Yield	24.52x
FCF Per Share	TWD 7.25
Financing CF	-130,981,000
Fiscal Year End	December
Founded	2,000
Goodwill	247,898,000
Graham Number	60.05371
Graham Upside	20.11
Income Tax	TWD 51.6M
Investing CF	-74,514,000
Is Primary Listing	1
Last Earnings Date	2026-02-24
Last Report Date	2026-06-30
Last Split Date	2013-08-28
Last Split Type	Forward
Lynch Fair Value	TWD 109
Lynch Upside	117.5
Ma150	51.39
Ma150ch	-2.71%
Ma20	50.37
Ma20ch	-0.73%
Net CF	74,508,000
Next Earnings Date	2026-09-14
Open	49.9
P FCF Ratio	6.89
P OCF Ratio	6.86
Payment Date	2026-07-13
Position In Range	42.86
Ppne	30,437,000
Price Date	2026-09-11
Price EBITDA	TWD 7.2
Ptbv Ratio	1.71
Relative Volume	0.63x
Revenue	1,396,614,000x
Tax By Revenue	3.7x
Tax Rate	19.09%
Tr6m	3.11%
Volume	23,151
Z Score	5.63

TPEX/8432 (TPEX/8432)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/8432

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/8432 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/8432

Frequently asked questions